Serum aminotransferase activity and mortality risk in a United States community.
about
Biomarker-Based Approaches for Assessing Alcohol Use DisordersThe association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition.Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.Assessing alcohol intake & its dose-dependent effects on liver enzymes by 24-h recall and questionnaire using NHANES 2001-2010 dataProtective effect of propofol preconditioning on ischemia-reperfusion injury in human hepatocyte.Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence.Impacts of common factors of life style on serum liver enzymes.Characteristics of chronic hepatitis B patients who underwent liver biopsies.Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.Risky alcohol use and serum aminotransferase levels in HIV-infected adults with and without hepatitis C.Complex association between alanine aminotransferase activity and mortality in general population: a systematic review and meta-analysis of prospective studies.Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RTLongitudinal Blood Pressure Control, Long-Term Mortality, and Predictive Utility of Serum Liver Enzymes and Bilirubin in Hypertensive Patients.Cell death and cell death responses in liver disease: mechanisms and clinical relevanceAssociations of Metabolic Syndrome and its Components With Mortality in the Elderly: A Cohort Study of 73,547 Taiwanese AdultsElevation of Serum Aminotransferase Levels and Future Risk of Death from External Causes: A Prospective Cohort Study in KoreaAssociation of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary interventionOngoing liver inflammation in patients with chronic hepatitis C and sustained virological responseElevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.Mild Hypertransaminasemia in Primary Care.Association Between Change in Serum Aminotransferase and Mortality: A Nationwide Cohort Study in Korea.Advances in pediatric nonalcoholic fatty liver disease.The association of low serum alanine aminotransferase activity with mortality in the US populationPerioperative risk assessment for patients with cirrhosis and liver disease.The genetic architecture of liver enzyme levels: GGT, ALT and AST.Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resectionBiomarkers of alcohol consumption and related liver disease.Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis.Low Alanine Aminotransferase Levels in the Elderly: Frailty, Disability, Sarcopenia and Reduced Survival.ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.Alanine aminotransferase and mortality in patients with type 2 diabetes (ZODIAC-38).A Point-based Mortality Prediction System for Older Adults with Diabetes.Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States.Liver function tests as indicators of metabolic syndromeAlanine aminotransferase: is it healthy to be "normal"?Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study.Healthy range for serum ALT and the clinical significance of "unhealthy" normal ALT levels in the Korean population.Co-occurrence of obesity and patterns of alcohol use associated with elevated serum hepatic enzymes in US adults.Chronic hepatitis B management based on standard guidelines in community primary care and specialty clinics.Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.
P2860
Q26772931-C638035E-4D4A-4622-81FB-BFA38C6A9B19Q31022208-BD1CAA62-EC7A-4C1D-860A-5643CF09B2A6Q31050092-D4D6CF00-4802-4AE1-8348-B1C3C625AB6EQ31110102-7CEFE227-7A0E-4BBC-87C1-CD0B3D015CD0Q33571312-5B391782-F997-4C52-B483-DF7ACBF5E13CQ33954722-BC9E9BBC-AF96-4E0A-B80A-4D5675673FD1Q34137334-C4212BF3-0226-44CA-BEB9-07C4EBD7433BQ34414362-9588E609-299B-449E-9114-77F07B1B0211Q34462246-05AC455E-3A10-486C-AB85-D537858B194FQ34577683-0704FC6A-9563-4FC6-86E4-25ACB341D094Q35122003-F3855A9C-D13E-4C0C-8255-A062D214B964Q35543638-EC961378-6BB7-4FF4-8AE6-2CE138F6F9A9Q35705464-2E08BB22-3C4A-4270-A154-D134122FB72CQ35938040-22B5C428-E9A5-478E-BCC7-B1E43F3A8775Q36194253-BAC5114D-B3E0-4934-AFAE-4B989C7EBE43Q36240154-CD949DE2-E064-4E87-93FB-0090F115D015Q36262814-E194D57F-5EBC-44DC-A18D-803D9D43488BQ36280109-B1EB3380-AA95-4384-B226-D1B36D06D198Q36326364-621533F3-37F0-4A43-A6B5-D697E95F497AQ36962095-FA1EF7FF-0E56-4CE5-B21E-CE54723D7BF9Q37205408-36E3A18D-D78C-4D83-9C97-30E6991673C1Q37376332-DC029F37-BD17-4F42-A38F-10C90115A74FQ37380522-3634FD3C-A70C-4E86-AFC5-011253A3C3C1Q37390653-9B481E42-B1D5-455F-B0A2-AC0894A54A11Q37569347-18968BF4-A809-4D3A-B5D5-BD8785AD8D4CQ37687816-9A8106E6-EDC5-4AE7-829B-D7894918AC2CQ37752443-64BF45ED-DE26-4F00-BFA0-EFE8FA2B9AEDQ38192584-55237D1B-71DC-4227-979B-136124E2FF8BQ38716877-BB6B3C55-6022-4A5E-84D2-19AC45EE549CQ40416496-0032BC42-867F-411C-83EC-785CB99F255EQ40866092-7D691F23-B334-4442-A050-3A231222BE65Q42281548-8AB89C48-6726-4E3D-9DC0-6A3E3A266DA9Q42439943-77A7FD92-676F-4634-8389-B28CD89FF8ECQ42580880-0710AC47-7C8A-4008-8B65-0829BC359317Q43235920-6648B962-5368-43D1-B7D6-E0F6F2439FF0Q43269850-88A533CD-A58C-44D8-BB46-502EEE462AD1Q43585965-590AB6FE-B243-4D4D-B302-F5C2B82146B7Q43990635-683DE787-E722-4FFE-80BF-2CCEB058AED2Q44767670-073B78EF-54E7-4A7D-811E-87C6C8CF0994Q46045006-33CD7F7E-62A4-442F-9D76-DB1D1E747130
P2860
Serum aminotransferase activity and mortality risk in a United States community.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Serum aminotransferase activity and mortality risk in a United States community.
@en
type
label
Serum aminotransferase activity and mortality risk in a United States community.
@en
prefLabel
Serum aminotransferase activity and mortality risk in a United States community.
@en
P2093
P2860
P356
P1433
P1476
Serum aminotransferase activity and mortality risk in a United States community
@en
P2093
Joanne T Benson
L Joseph Melton
Terry M Therneau
P2860
P304
P356
10.1002/HEP.22090
P407
P577
2008-03-01T00:00:00Z